ixabepilone inn also known azaepothilone b codenamed pharmaceutical drug developed bristolmyers squibb chemotherapeutic medication ixabepilone semisynthetic analog epothilone b natural chemical compound produced sorangium epothilone b could developed pharmaceutical drug poor metabolic stability ixabepilone designed medicinal chemistry improve upon much like taxol ixabepilone acts stabilize highly potent capable damaging cancer cells low concentrations retains activity cases tumor cells insensitive taxane type october us food drug administration approved ixabepilone treatment aggressive metastatic locally advanced breast cancer longer responding currently available november emea refused marketing authorisation ixabepilone administered injection marketed trade name ixempra ixabepilone combination capecitabine demonstrated effectiveness treatment metastatic locally advanced breast cancer patients failure anthracycline investigated use treatment nonhodgkins pancreatic cancer phase two trial showed promising results used alone combination therapy trials httpsenwikipediaorgwikiixabepilone